Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gansu Pu'an Pharmaceutical is a Chinese pharmaceutical company that specializes in the development, production, and sale of Traditional Chinese Medicine (TCM). The company is best known for its flagship product, Xuanfei Zhike Particles, which is widely utilized for treating respiratory conditions such as cough and bronchitis. Based in Wuwei, Gansu Province, it operates as a subsidiary of the Gansu Farm Cultivation Drug Industry Group. The company maintains modern, GMP-certified manufacturing facilities capable of large-scale herbal extraction and granule production. Its products are integrated into China's national medical insurance system and have been featured in official treatment protocols for respiratory diseases. Gansu Pu'an Pharmaceutical focuses on the industrialization of TCM through scientific research and standardized manufacturing processes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gansu Pu'an Pharmaceutical.